Document Page: First | Prev | Next | All | Image | This Release | Search

File: 123096_sep96_decls23_0026.txt
Page: 0026
Total Pages: 52

Subject: DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANCE               

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: DIAGNOSIS AND TREATMENT OF DISEASES  1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS                

Document Number:          1

Folder Seq  #:         88









            3.   Mefloquine, 250 mg tablets, 1250 mg (5 tablets) as
                 a single dose.
                 a.    Toxicities of mefloquine: CHS effects                                                     KENINGOCOCCAL DISEASE
                       (psychosis, confusion, and seizures) and
                       cardiac toxicity may be seen. Avoid concur-                        1.    Communicability:
                       rent use of quinine, quinidine, beta-blocking
                       agents or calcium-channel blockers.                                      A.   Route: person to person by respiratory droplets.
       Disposition:                                                                             B.   isolation of patients: respiratory isolation for first
      A.    For uncomplicated cases:    local hospitalization for up                                 24 hours of antibiotic therapy, disinfect nasal and
            to 48 hours, with limited duty for several days                                          pharyngeal secretions and material contaminated with
            drug therapy is completed).                           (until                             them.
                                                                                                C.   Prophylaxis of contacts:
      B.    For complicated cases, including cerebral malaria,                                       1.     intimate and household contacts, including bar-
            ARDS, "Blackwater Fever," and renal failure: vacua-                                             racks and tent-mates should receive:
            tion to third or fourth echelon facilities will be                                              a.  rifampin 600 mg PO Q12h for 4 doses, or
            needed.                                                                                             ceftriaxone 250 mg IM, one dose, or
 ciprofloxacin 500 mg PO Q12h for 5 days,
                                                                                                            b.  meningococcal vaccine, unless this has been
      A.    P. vivax: excellent if treated; mortality low, even if                                              received within two years.
            untreated, and complications are rare.                                                   2.     casual contacts need not receive prophylaxis.

      B.    P. falciparum:                                                                II. Incubation: 3 to 4 days (range 2 to 10 days).
            1.   Untreated  25% or more will be fatal.
            2.   Properly treated uncomplicated cases do well,                            III. Diagnosis: meningococcal infection may be asymptomatic, or
                 without sequelae.
                                                                  on the                             sequelae), as meningitis, as fulminant septicemia
            3.   The prognosis for complicated cases depends                                         may present as a self-limited flu-like illness (without
                 specific complications; however, the potential for                                  (meningococcemia) or as combined meningitis-septicemia.
                 full recovery exists even for critically ill,                                       Clinical signs and symptoms will vary with the type of
                 complicated cases who should, therefore, be                                         presentation.
                 managed aggressively.
      Public health measures:                                                                   A.   Symptoms:
                                                                                                     1.     Meningococcemia: very abrupt onset with fulminant
                                                                                                            course:
Command emphasis on Personal protection measures                                                    fever
            (chemoprophylaxis, repellents and netting) in endemic                                               headache
            areas.                                                                                              malaise
      B.    Mosquito control: elimination of breeding sites,                                                    diarrhea (occasionally may be severe)
            larvicide applications and insecticide applications to                                   2.     Meningitis: onset may be abrupt or subacute
            kill adult mosquitoes.                                                                          (several days):
                                                                                                                headache
                                                                                                                fever
                                                                                                                malaise
                                                                                                                photophobia
                                                                                                                nausea/vomiting
                                                                                                                back ache




                                   42

                                                                                                                             43

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 52 f:/Week-36/BX003203/DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS/diagnosis and treatment of diseases of importanc:12179609281524
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = DIAGNOSIS AND TREATMENT OF DISEASES 1991PORTABLE FIELD PERSONNEL SHOWER SYSTEMS
Folder Seq # = 88
Subject = DIAGNOSIS AND TREATMENT OF DISEASES OF IMPORTANC
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996